Cargando…
The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome
BACKGROUND: Negatively charged very-low-density lipoprotein (VLDL-χ) in metabolic syndrome (MetS) patients exerts cytotoxic effects on endothelial cells and atrial myocytes. Atrial cardiomyopathy, manifested by atrial remodeling with a dilated diameter, contributes to atrial fibrillation pathogenesi...
Autores principales: | Lee, Hsiang-Chun, Shin, Shyi-Jang, Huang, Jih-Kai, Lin, Ming-Yen, Lin, Yu-Hsun, Ke, Liang-Yin, Jiang, He-Jiun, Tsai, Wei-Chung, Chao, Min-Fang, Lin, Yi-Hsiung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507670/ https://www.ncbi.nlm.nih.gov/pubmed/32962696 http://dx.doi.org/10.1186/s12944-020-01386-5 |
Ejemplares similares
-
The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome
por: Lee, Hsiang-Chun, et al.
Publicado: (2020) -
Very Low-Density Lipoproteins of Metabolic Syndrome Modulates STIM1, Suppresses Store-Operated Calcium Entry, and Deranges Myofilament Proteins in Atrial Myocytes
por: Shiou, Yi-Lin, et al.
Publicado: (2019) -
Association of lipid composition and unsaturated fatty acids of VLDL with atrial remodeling in metabolic syndrome
por: Lee, Hsiang-Chun, et al.
Publicado: (2023) -
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
por: Huang, Jih-Kai, et al.
Publicado: (2022) -
Very-Low-Density Lipoprotein of Metabolic Syndrome Modulates Gap Junctions and Slows Cardiac Conduction
por: Lee, Hsiang-Chun, et al.
Publicado: (2017)